Want to see HK:6186 full AI Analyst Report?
6186 Stock Chart & Stats
HK$3.17
HK$0.02(0.62%)
At close: 4:00 PM EDT
HK$3.17
HK$0.02(0.62%)
Day’s Range― - ―
52-Week RangeHK$2.79 - HK$4.64
Previous CloseN/A
Volume18.36M
Average Volume (3M)26.36M
Market Cap
HK$29.16B
Enterprise ValueHK$21.50K
Total Cash (Recent Filing)HK$16.30B
Total Debt (Recent Filing)HK$855.59M
Price to Earnings (P/E)13.1
Beta0.60
Next Earnings
Aug 26, 2026EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend Yield7.76%
Share Statistics
EPS (TTM)0.21
Shares Outstanding9,067,252,000
10 Day Avg. Volume24,266,952
30 Day Avg. Volume26,356,611
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)1.38
Price to Sales (P/S)1.86
P/FCF Ratio52.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.43Price Target Upside8.20% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.28
Revenue Forecast (FY)HK$18.22B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage gives Feihe a resilient funding structure, reducing refinancing pressure and preserving flexibility to support production, brand investment, and operations during periods of weaker demand.
Strong Gross MarginThe still-high gross margin indicates that Feihe retains meaningful product economics and brand or formulation value, providing a buffer against cost pressures and supporting profitability if revenue stabilizes.
Branded And Integrated Business ModelA branded infant-nutrition portfolio combined with control over sourcing and production can support product quality, supply reliability, and cost management, creating durable advantages in a trust-sensitive category.
Bears Say
Revenue ContractionA material annual revenue decline signals weakening demand, market share, or product mix. Sustained contraction would reduce operating leverage and make it harder to fund brand development and maintain scale advantages.
Profit Margin CompressionThe sharp decline in net margin shows that weaker pricing, mix, or cost absorption is affecting earnings quality. Continued compression could limit reinvestment capacity even if gross margins remain relatively strong.
Weaker Cash GenerationReduced operating and free cash flow means accounting profits are converting into cash less effectively. This may reflect working-capital or investment needs and could constrain future reinvestment, distributions, or resilience.
China Feihe Limited News
6186 FAQ
What was China Feihe Limited’s price range in the past 12 months?
China Feihe Limited lowest stock price was HK$2.79 and its highest was HK$4.64 in the past 12 months.
What is China Feihe Limited’s market cap?
China Feihe Limited’s market cap is HK$29.16B.
When is China Feihe Limited’s upcoming earnings report date?
China Feihe Limited’s upcoming earnings report date is Aug 26, 2026 which is in 3 days.
How were China Feihe Limited’s earnings last quarter?
China Feihe Limited released its earnings results on Mar 26, 2026. The company reported HK$0.14 earnings per share for the quarter, missing the consensus estimate of HK$0.175 by -HK$0.035.
Is China Feihe Limited overvalued?
According to Wall Street analysts China Feihe Limited’s price is currently Undervalued.
Does China Feihe Limited pay dividends?
China Feihe Limited pays a Semiannually dividend of HK$0.129 which represents an annual dividend yield of 7.76%. See more information on China Feihe Limited dividends here
What is China Feihe Limited’s EPS estimate?
China Feihe Limited’s EPS estimate is 0.16.
How many shares outstanding does China Feihe Limited have?
China Feihe Limited has 9,067,252,000 shares outstanding.
What happened to China Feihe Limited’s price movement after its last earnings report?
China Feihe Limited reported an EPS of HK$0.14 in its last earnings report, missing expectations of HK$0.175. Following the earnings report the stock price went down -2.636%.
Which hedge fund is a major shareholder of China Feihe Limited?
Currently, no hedge funds are holding shares in HK:6186
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Feihe Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
HK$3.43 (8.20% Upside)
HK$3.43 (8.20% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.66%
12-Months-Change
Fundamentals
Return on Equity
7.76%
Trailing 12-Months
Asset Growth
-0.28%
Trailing 12-Months
Company Description
China Feihe Limited
China Feihe Limited operates as an investment holding entity primarily engaged in the production and sale of infant formula, serving consumers across Mainland China and the United States. Its comprehensive product portfolio extends to include raw and liquid milk, adult milk powders, various healthcare products, and specialized powders like soybean and goat milk. Furthermore, the company retails vitamins, minerals, herbal supplements, and other nutritional items. Products reach consumers through a multi-channel approach, utilizing third-party distributors, prominent e-commerce platforms such as Tmall, JD.com, and Suning.com, alongside its official website and mobile applications, including WeChat. By December 31, 2021, its extensive distribution network involved approximately 2,000 offline customers, managing 110,000 retail points of sale. China Feihe Limited was established in 1962 and is headquartered in Beijing, People's Republic of China.
6186 Stock 12 Month Forecast
Average Price Target
HK$3.43
▲(8.20% Upside)
Technical Analysis
Want Want China Holdings
―
Health and Happiness (H&H) International Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
Ausnutria Dairy Corp. Ltd.
―